Free Float 4,30 %
Shares Float 9,45 M
Shares Outstanding 219,78 M
SYNLAB AG Share · DE000A2TSL71 (XFRA) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of SYNLAB AG
No Price
Share Float & Liquidity
Company Profile for SYNLAB AG Share
SYNLAB AG provides clinical laboratory and medical diagnostic services for insurance companies, hospitals, pharmacies, national health organizations, practicing doctors, clinics, patients, governments, and corporations primarily in Europe. The company offers Coronavirus tests, and medical and veterinary diagnostics services. It operates through approximately 500 laboratories and 1,800 blood collection points in 36 countries in four continents. The company was founded in 1998 and is headquartered in Munich, Germany.
Company Data
Name SYNLAB AG
Company Synlab AG
Website
https://www.synlab.com
Primary Exchange 
Frankfurt
Frankfurt
ISIN DE000A2TSL71
Asset Class Share
Sector Healthcare
Industry Medical - Diagnostics & Research
CEO Mathieu Floreani
Market Capitalization 2 Mrd.
Country Germany
Currency EUR
Employees 27,0 T
Address Moosacher Straße 88, 80809 Munich
IPO Date 2021-04-30
Dividends from 'SYNLAB AG'
| Ex-Date | Dividend per Share |
|---|---|
| 20.05.2024 | 0,33 EUR |
| 18.05.2023 | 0,33 EUR |
| 17.05.2022 | 0,33 EUR |
Ticker Symbols
| Name | Symbol |
|---|---|
| Frankfurt | SYAB.F |
| XETRA | SYAB.DE |
More Shares
Investors who hold SYNLAB AG also have the following shares in their portfolio:
